Lexicon Pharmaceuticals Inc.

04/29/2024 | Press release | Distributed by Public on 04/29/2024 07:01

Management Change/Compensation - Form 8-K

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

(b) On April 24, 2024, Lonnel Coats notified us of his retirement as our chief executive officer (in which capacity, Mr. Coats functions as our principal executive officer) and as a member of our board of directors, in each case effective July 7, 2024. Our board of directors has initiated a search for a new chief executive officer which will consider both internal and external candidates.